RxDoctor Payments Data

Andrew Chung, DO

Orthopaedic Surgery · Los Angeles, CANPI 1750709036

Payments from drug & device makers

$84,124in general payments, 2019–2025

Across 342 payments — averaging $245.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amplify Surgical, Inc.$20K
  • Si-bone, Inc.$11K
  • Medtronic$10K
  • L&k Spine Inc$8K
  • L&k Biomed CO. , LTD.$7K
  • Globus Medical$6K
  • plus $23K from 33 others
$11,586in research payments, 2019–2025

Across 4 payments — averaging $2896.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spinal Elements, Inc.$12K

What the payments were for

  • Consulting fees$23,50028%
  • Speaking & faculty fees$5,1006%
  • Travel & lodging$33,73440%
  • Food & beverage$18,94323%
  • Education$2,8463%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$84,124 in reported general payments places this provider in the 85th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$259,733
Medicare patients
383
Services billed
1,189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin37$227
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$151
Meloxicam41$82
Methylprednisolone12$75

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →